Ra Medical Systems to Merge with Catheter Precision

Ra Medical Systems and Catheter Precision have entered into an Agreement and Plan of Merger that Catheter Precision will become a wholly owned subsidiary of Ra Medical in a stock-for-stock reverse merger transaction, resulting in a combined publicly traded company that will focus on the cardiac electrophysiology market.

David Jenkins, Catheter Precision founder and CEO, will act as Chief Executive Officer of the combined company. Mr. Jenkins was instrumental in operating several medical device start-ups, including Transneuronix which was acquired by Medtronic for $267 million in July 2005, and EP MedSystems which was acquired by St. Jude Medical for $95.7 million in July 2008.

This business combination will result in Ra Medical investors having an equity stake in a company that is focused on developing and commercializing novel technologies and solutions to improve the lives of patients with cardiac arrhythmias, according to Will McGuire, Ra Medical CEO.